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Evidence suggests exposure to particulate matter with aerodynamic diameter 52.5 km (PM2.5) may increase the risk for
Alzheimer’s disease and related dementias. Whether PM2.5 alters brain structure and accelerates the preclinical neuropsychological
processes remains unknown. Early decline of episodic memory is detectable in preclinical Alzheimer’s disease. Therefore, we
conducted a longitudinal study to examine whether PM2.5 affects the episodic memory decline, and also explored the potential
mediating role of increased neuroanatomic risk of Alzheimer’s disease associated with exposure. Participants included older females
(n = 998; aged 73–87) enrolled in both the Women’s Health Initiative Study of Cognitive Aging and the Women’s Health Initiative
Memory Study of Magnetic Resonance Imaging, with annual (1999–2010) episodic memory assessment by the California Verbal
Learning Test, including measures of immediate free recall/new learning (List A Trials 1–3; List B) and delayed free recall (short-
and long-delay), and up to two brain scans (MRI-1: 2005–06; MRI-2: 2009–10). Subjects were assigned Alzheimer’s disease
pattern similarity scores (a brain-MRI measured neuroanatomical risk for Alzheimer’s disease), developed by supervised machine
learning and validated with data from the Alzheimer’s Disease Neuroimaging Initiative. Based on residential histories and envir-
onmental data on air monitoring and simulated atmospheric chemistry, we used a spatiotemporal model to estimate 3-year average
PM2.5 exposure preceding MRI-1. In multilevel structural equation models, PM2.5 was associated with greater declines in imme-
diate recall and new learning, but no association was found with decline in delayed-recall or composite scores. For each inter-
quartile increment (2.81 kg/m3) of PM2.5, the annual decline rate was significantly accelerated by 19.3% [95% confidence interval
(CI) = 1.9% to 36.2%] for Trials 1–3 and 14.8% (4.4% to 24.9%) for List B performance, adjusting for multiple potential
confounders. Long-term PM2.5 exposure was associated with increased Alzheimer’s disease pattern similarity scores, which ac-
counted for 22.6% (95% CI: 1% to 68.9%) and 10.7% (95% CI: 1.0% to 30.3%) of the total adverse PM2.5 effects on Trials 1–3
and List B, respectively. The observed associations remained after excluding incident cases of dementia and stroke during the
follow-up, or further adjusting for small-vessel ischaemic disease volumes. Our findings illustrate the continuum of PM2.5 neuro-
toxicity that contributes to early decline of immediate free recall/new learning at the preclinical stage, which is mediated by
progressive atrophy of grey matter indicative of increased Alzheimer’s disease risk, independent of cerebrovascular damage.
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Introduction
Exposure to ambient air pollution represents a novel envir-
onmental risk factor of accelerated brain ageing
(Underwood, 2017). In recent years, a growing number
of epidemiological studies have shown that fine particulate
matter with aerodynamic diameter 52.5 mm (PM2.5) may
increase the risk of dementia, including Alzheimer’s disease
(Jung et al., 2015; Cacciottolo et al., 2017; Chen et al.,
2017; Carey et al., 2018; Oudin et al., 2018).
Toxicopathological studies suggest air pollution accelerates
amyloid-b accumulation in mice (Bhatt et al., 2015;
Cacciottolo et al., 2017) and neurofibrillary tangles in ca-
nines (Calderón-Garcidueñas et al., 2003). Despite the
increasing evidence supporting the neurological effects of
PM2.5 on Alzheimer’s disease and related dementias, defini-
tive conclusions on the causal association cannot be made
because the underlying mechanisms remain unclear (The
Lancet Neurology, 2018).
Declines in verbal episodic memory (e.g. the ability to
remember details, with context, from daily and remote
experiences) are the hallmark symptom of Alzheimer’s dis-
ease detectable in the preclinical stage (Gallagher and
Koh, 2011). Episodic memory is composed of distinct cog-
nitive processes such as encoding the target information
(learning) and subsequently retrieving the target informa-
tion, each involving complex neural systems (Dickerson
and Eichenbaum, 2010). Several animal studies have
demonstrated that inhaled PM2.5 exposures affect various
neural systems thought to underlie these episodic memory
processes (Fonken et al., 2011; Cheng et al., 2017; Ku et
al., 2017; Liu et al., 2018). Few longitudinal epidemiolo-
gical studies examined the association between PM2.5 and
episodic memory (Weuve et al., 2012; Tonne et al., 2014;
Wurth et al., 2018), and the majority of these studies used
composite scores with mixed results. Importantly, no pre-
vious studies had directly linked air pollution exposures
with cognitive decline and altered brain structure predict-
ive of dementia risk. Therefore, we conducted a longitu-
dinal study to examine the association between long-term
exposure to PM2.5 and decline in episodic memory (imme-
diate recall/new learning; delayed-recall), and to investi-
gate the extent to which the putative adverse PM2.5
effects on declines were mediated by changes in neuroa-
natomic structure indicative of increased Alzheimer’s dis-
ease risk.
Materials and methods
Study design and population
We conducted a prospective cohort study that included com-
munity-dwelling females who were initially enrolled in the
Women’s Health Initiative (WHI) Memory Study and subse-
quently participated in both the WHI Study of Cognitive
Aging (WHISCA) and the WHI Memory Study of Magnetic
Resonance Imaging (WHIMS-MRI) ancillary studies (Resnick
et al., 2009; Coker et al., 2014). WHIMS participants (n =
7479) were postmenopausal females aged 65 years and older
who were recruited from 1996 through 1999 across 48 states
and free of dementia as determined by standardized study
protocols, described elsewhere (Shumaker et al., 2004)
(Supplementary material). A subsample of cognitively-intact
WHIMS participants (n = 2304) were followed in WHISCA
with annual neurocognitive testing during the period of 1999–
2010. Between April 2005 and January 2006, WHIMS partici-
pants (n = 1403) across 14 (of 38) active WHIMS sites were
enrolled in the WHIMS-MRI study, yielding 1365 scans that
met quality control standards. A total of 1050 females parti-
cipated in both WHISCA and WHIMS-MRI. For the present
study, we excluded subjects with missing data on relevant
covariates, resulting in a final analytic sample of 998 females
(Fig. 1). A total of 531 females underwent a second MRI be-
tween 2009 and 2010.
Measures of episodic memory
Episodic memory was assessed using the California Verbal
Learning Test (CVLT), focusing on immediate recall, new
learning, and delayed-recall (Delis et al., 1987). Participants
were read a 16-item list of words (List A) from four seman-
tically-related categories. Each time the list was read the par-
ticipant was instructed to immediately repeat back as many
words as she could remember. In WHISCA, participants
were administered only three learning trials. After completion
of the List A trials, a single learning/recall trial of the alternate
List B items was administered. Promptly after the List B ‘inter-
ference’ trial, the participants were asked to freely recall all
words from List A (short-delay free recall). After an approxi-
mate 20-min delay, the free recall trials were repeated (long-
delay free recall). For the outcome variables, we used the total
number of correct responses on each measure: (i) List A learn-
ing trials 1–3; (ii) List B learning/recall trial; (iii) List A short-
delay free recall; and (iv) List A long-delay free recall. Each
measure was Z-score standardized based on the mean and
standard deviation (SD) at the initial WHISCA assessment.
The Z-scores for these three List A measures were averaged
to create the composite score of CVLT performance.
WHIMS-MRI acquisition and
processing
MRI scans were performed using standardized scan acquisition
protocols developed by the MRI Quality Control Center (Resnick
et al., 2009). Standard T1-, T2-, proton density-weighted, and
fluid-attenuated inversion recovery (FLAIR) scans were acquired
with a 22-cm field of view and a matrix of 256  256 in 1.5 T
scanners at 14 sites. Included were oblique axial spin density/T2-
weighted spin echo (repetition time = 3200 ms, echo time = 30/
120 ms, slice thickness = 3 mm), FLAIR T2-weighted spin echo
(repetition time = 8000 ms, inversion time = 2000 ms, echo time
= 100 ms, slice thickness = 3 mm), and oblique axial 3D T1-
weighted gradient echo (flip angle = 30, repetition time = 21
ms, echo time = 8 ms, slice thickness = 1.5 mm) images from the
vertex to the skull base parallel to the anterior commissure–pos-
terior commissure plane.
As part of the WHIMS-MRI protocol developed by the read-
ing centre, a brain lesion segmentation algorithm was applied
to T1-, T2-, and FLAIR scans to segment small-vessel ischaemic
disease (SVID) (Lao et al., 2008). By combining the tissue
segmentation and lesion segmentation algorithm, each voxel
was classified as either normal (not SVID-affect) or abnormal
(SVID-affected). Normal-appearing brain volume and SVID
volumes in grey and white matter regions were calculated,
then abnormal brain volumes in these regions were combined
to classify total SVID volume.
Joint brain MRI data processing
across two populations
We used high-dimensional warping methods to process struc-
tural brain MRI images (T1-weighted) from WHIMS-MRI
participants. More details about the MRI data processing
across dataset can be found in other reports (Tustison et al.,
2014; Casanova et al., 2018). Here, we briefly describe the
main steps. The Advanced Normalization Tools software was
used to align the brain images from the WHIMS-MRI and the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) into a
common template. The images were submitted to N4 bias
field correction (Tustison et al., 2010), brain extraction, seg-
mentation (Avants et al., 2011), template construction and
normalization. A script consisting of six stages (brain extrac-
tion, template registration, tissue segmentation, improved tem-
plate registration, cortical thickness registration, and quality
control and summary measurements) was used to generate
the template based on a randomly selected sample of 50 cog-
nitively normal Caucasian females (55–90 years old; mean age:
76.8) from ADNI. The brain MRI images (n = 2436) from
both WHIMS-MRI and ADNI were segmented and warped to
the template.
Alzheimer’s disease pattern similarity
score
The Alzheimer’s disease pattern similarity (AD-PS) score was
derived using a high-dimensional (voxel-wise) supervised ma-
chine learning algorithm based on the elastic net regularized
logistic regression (EN-RLR) to analyse structural brain MRI
Figure 1 Flowchart for selection of final analytical sample.
data pattern at voxel level (Friedman et al., 2010), comparing
Alzheimer’s disease cases and cognitively normal individuals
(Casanova et al., 2011). The EN-RLR is known to produce
sparse models (Zou and Hastie, 2005), which translates in the
context of our neuroimaging application into a variable selec-
tion mechanism able to identify voxels or brain areas relevant
for classification that we call discriminative maps. The score
formally is the class-conditional probability of membership to
the Alzheimer’s disease group as modelled by the EN-RLR
model when discriminating cognitively normal from
Alzheimer’s disease participants in ADNI (Casanova et al.,
2013), interpreted as a measure of similarity of the brain spa-
tial patterns found in one individual’s MRI to those found in
individuals diagnosed with Alzheimer’s disease.
The AD-PS scores of WHIMS MRI participants were derived
by two steps: (i) estimating the EN-RLR classifier based on
grey matter probability maps from cognitively-normal and
Alzheimer’s disease participants in ADNI; and (ii) providing
baseline and follow-up WHIMS-MRI grey matter probability
maps as input to the EN-RLR classifier to generate the grey
matter AD-PS score for WHIMS-MRI participants. The dis-
criminative maps derived in step (i) revealed grey matter atro-
phies in areas (e.g. amygdala, hippocampus, para-hippocampal
gyrus, thalamus, inferior temporal lobe areas and midbrain)
where Alzheimer’s disease neuropathologies are thought to
first emerge (Brettschneider et al., 2015). We had previously
reported both cross-sectional and longitudinal relationships of
higher AD-PS scores with increased age, poorer cognitive
performance, and greater SVID volume in WHIMS-MRI par-
ticipants (Casanova et al., 2018). In a longitudinal analysis of
global cognitive trajectories over 10 years, the groups of older
females with relatively lower AD-PS scores were considered
more resilient to cognitive decline (Espeland et al., 2018).
Our empirical data also showed that an SD (=0.23) increase
in AD-PS scores over a 5-year period was associated with a
122% increase in dementia risk [hazard ratio = 2.22; 95%
confidence interval (CI): 1.80 to 2.75] defined by DSM-IV
criteria, adjusting for socio-demographics, region, lifestyle fac-
tors, and clinical characteristics.
Air pollution exposure assessment
Residential addresses of WHIMS participants were prospect-
ively collected during each clinic visit and updated at least
biannually. Residential histories were then sent to a single
vendor that followed standardized protocols for geocoding
(Whitsel et al., 2004). Ambient concentration of PM2.5 was
estimated using the Bayesian maximum entropy (BME)-based
spatiotemporal modelling approach, integrating nationwide
monitoring data from both the US Environmental Protection
Agency (EPA) Air Quality System (AQS) and the output of
chemical transport models, entitled Community Multiscale
Air Quality (Reyes et al., 2017). Our empirical data showed
that the BME estimates of daily PM2.5 exposures correlated
well with recorded concentrations from the AQS (average
cross-validation Pearson’s R2 = 0.70). The statistically-vali-
dated BME model was then applied to each geocoded residen-
tial location, accounting for residential mobility in 1999–2010,
and exposure estimates were then aggregated to represent the
average PM2.5 3 years preceding the first MRI scan. See
Supplementary material for further details.
Covariate data
A structured questionnaire was administered to participants at
WHIMS enrolment to gather information on demographics
[e.g. age; race/ethnicity (Black/African-American, Hispanic
White, non-Hispanic White, other/missing)], socioeconomic
factors [e.g. education (5high school, high school/GED,
4high school); family income (5$10 000, $10 000–34 999,
$35 000–74 999, 5$75 000); employment status (currently
employed, not working, retired)], and lifestyle factors [e.g.
smoking status (never smoked, past smoker, current smoker);
alcohol intake (non-drinker, past drinker, 51 drink per day,
41 drink per day); physical activity (no activity, some activity,
2–4 episodes per week, 44 episodes per week)]. Additionally,
clinical characteristics were ascertained including any postme-
nopausal hormone treatment ever, history of cardiovascular
disease [including previous coronary heart disease (e.g. myo-
cardial infarction, coronary angioplasty, or coronary artery
bypass graft), stroke, or transient ischaemic attack, hyperten-
sion [defined as elevated blood pressure (systolic 5140 or dia-
stolic 590 mmHg), or use of antihypertensive medication],
and diabetes mellitus (defined as physician diagnosis plus
oral medications, or insulin therapy). Good reliability and val-
idity of both the self-reported medical histories and the phys-
ical measures have been previously documented (Heckbert
et al., 2004; Johnson-Kozlow et al., 2007; Margolis et al.,
2008).
Statistical analysis
We constructed multilevel structural equation models (SEM) to
characterize the longitudinal trajectory of each CVLT measure
and examined the respective association with PM2.5 exposure.
Years across repeated CVLT assessments were used as the time
scale, centred on the individual-specific date of the first MRI
(MRI-1). The average trajectories of CVLT performance were
assumed to follow piecewise-linear declines joined at MRI-1.
The multilevel SEM allowed for one random intercept (repre-
senting CVLT performance at MRI-1) and two random slopes
(individual-specific linear changes before and after the MRI-1),
while accounting for the practice effect and the use of two
CVLT forms, as defined in the within-individual portion of
SEM (Supplementary material, Equation 1). These individual-
specific parameters of individual trajectories were entered into
the between-individual portion of the multilevel SEM to assess
the associations between PM2.5 exposure and linear change in
CVLT. To ensure the appropriate temporal relations between
PM2.5 and identified CVLT trajectories, the relevant exposure
time window was defined as 3 years preceding the MRI-1,
with the resulting effect on annual rate of CVLT change
after MRI-1. The between-individual portion of the fully ad-
justed multilevel SEM is depicted in Fig. 2A and in the
Supplementary material. Separate SEMs were run for each
CVLT measure and composite score.
The estimated PM2.5 exposure effects on CVLT performance
at MRI-1 and change post MRI-1 were all adjusted for the
following covariates: age at MRI-1, race/ethnicity, geographic
region of residence, education, household income, employment
status, lifestyle factors (smoking; alcohol use; physical activ-
ities), and clinical characteristics (any prior hormone use
ever, hypercholesterolaemia, hypertension, diabetes, and his-
tory of cardiovascular disease).
We used multilevel SEMs with parallel-process mediation
(Cheong et al., 2003) to assess whether increased AD-PS
scores mediated the adverse PM2.5 effects, if any observed on
the post MRI-1 decline in CVLT performance. Figure 2B de-
picts the between-individual portion of the fully adjusted par-
allel process mediation SEM. AD-PS scores at MRI-1 and
average annual changes in AD-PS [(AD-PSMRI2  AD-
PSMRI1)/years between MRI assessments] were added as vari-
ables to the between-individual portion of the multilevel
model. The indirect effect, defined as the extent to which
change in AD-PS score mediated the PM2.5 effect on CVLT
change, was estimated by multiplying the two SEM paths: (i)
the effect of PM2.5 on change in AD-PS score; and (ii) the
effect of change in AD-PS score on change in CVLT. We
then estimated the direct effect of PM2.5 on CVLT change,
defined as the PM2.5 exposure effects on post MRI-1 change
in CVLT performance, independent of change in AD-PS score.
Using the approach described by Cheong et al. (2003) and
MacKinnon et al. (2002), we estimated the proportion of the
total PM2.5 effect (the sum of the direct and indirect effect) on
CVLT change that was mediated by changes in AD-PS score.
In fully-adjusted multilevel parallel-process mediation SEMs,
the PM2.5 effects on the outcome variables (CVLT perform-
ance at MRI-1; annual change post MRI-1) and the putative
mediators (AD-PS score at MRI-1 and subsequent change in
AD-PS score) were all adjusted for the same set of covariates
as described in the multilevel SEM models examining the
PM2.5 effect on CVLT trajectories.
Several additional analyses were conducted to examine the
robustness of our findings. To assess the possible confounding
by neighbourhood socioeconomic characteristics, the SEMs
further adjusted for census track-level socioeconomic
Figure 2 Depiction of the SEMs constructed. (A) Panel shows the portion of the fully adjusted multilevel SEM examining the associations
between PM2.5 exposure and level and change in CVLT performance. (B) Panel depicts parallel-process mediation SEM estimating the extent to
which change in AD-PS score mediates the association between long-term fine particulate matter exposure and declines in episodic memory.
characteristics of residential neighbourhood (Qi et al., 2012)
closest to MRI-1 (Supplementary material). To explore
whether any observed associations between PM2.5 and CVLT
decline simply reflect the underlying dementia risk, we re-
peated our analyses after excluding incident dementia cases
before the year 2010. To explore whether any observed asso-
ciations could be explained by cerebrovascular disease and
associated damage, we excluded incident stroke cases by
2010 (Supplementary material) and further adjusted for
global SVID volume in the mediation analyses. We also con-
ducted ad hoc mediation analyses by replacing the AD-PS
score with global grey matter volume, to illustrate whether
the associations between PM2.5 and CVLT decline may be
mediated by standard volumetric measures of global grey
matter atrophy. To assess the possible unmeasured confound-
ing by other factors that may operate through affecting the
pre-MRI trajectories, we ran a sensitivity analysis allowing
the correlation between exposure and the change in CVLT
performance before MRI-1. Lastly, to ensure we were not
overfitting the covariate structure, we constructed an alterna-
tive SEM where the estimated PM2.5 effect on the post MRI-1
trajectory was only adjusted for the selected covariates signifi-
cantly associated with changes in CVLT performance after
MRI-1. All analyses were performed using MPLUS version 8
(Muthén and Muthén, 1998–2018) via the MPLUS automa-
tion package (Hallquist and Wiley, 2018) in R version 3.5.1.
Data availability
Access to all data elements used in this study may be made
available following the established WHI policies.
Results
Population characteristics
The majority of the older females in our study population
were Caucasian (92.0%) and had more than a high-school
education (75.4%). Table 1 compares the distribution of
the 3-year average PM2.5 exposure prior to MRI-1, strati-
fied by population characteristics. Participants exposed to
higher levels of PM2.5 were more likely to self-identify as
African-American or Hispanic, reside in the West, and
report higher household incomes (5$75 000). Our study
sample (n = 998) and the excluded subjects (n = 367)
did not significantly differ by race/ethnicity, employment
status, household income, smoking status, alcohol use, or
selected clinical characteristics including hypertension, dia-
betes, or cardiovascular disease (Supplementary Table 1).
Compared to females from the WHIMS-MRI cohort who
were excluded from our final analytic sample, subjects
included in our analyses were more likely to reside in the
Midwest (P 5 0.01), were more educated (P 5 0.01), and
reported more physical activities (P = 0.02), and also
tended to have high cholesterol (P = 0.07) and use hor-
mone treatment (P = 0.06). We also compared the popu-
lation characteristics of our final sample (n = 998) by those
who did (n = 531) and did not (n = 467) return for their
second MRI scan (Supplementary Table 1). Compared to
females who did not return, MRI-2 participants were
more likely to reside in the Midwest and Northeast regions
(P 5 0.01) and self-identify as non-Hispanic White (P =
0.01), but were less likely to report having hypertension
(P = 0.02).
Associations between PM2.5 exposure
and change in CVLT
Multilevel SEMs revealed significant linear declines in epi-
sodic memory before MRI-1 across all CVLT measures
(Supplementary Table 2 with estimated population trajec-
tories). Linear declines in CVLT performance were gener-
ally larger after the MRI-1 across all measures except for
long-delay free recall. The observed between-individual
variability was statistically significant for the level of
CVLT performance at the MRI-1 and linear changes in
individual-specific estimates of all CVLT trajectories
before MRI-1. Between-individual variability in change
was generally larger after the MRI-1 but not statistically
significant.
Across all CVLT measures, PM2.5 exposure was not asso-
ciated with the estimated level of performance at MRI-1
(Table 2, top section). There was evidence for adverse
PM2.5 effects with greater declines in both CVLT measures
of immediate recall and new learning (List A learning Trials
1–3 and List B learning/recall trial), but no statistically sig-
nificant associations were found with delayed-recalls or
composite measure (Table 2, bottom section). Across each
interquartile increment of PM2.5 (2.81 mg/m
3), the average
rate of annual decline in immediate recall/new learning was
significantly accelerated by 0.040 SDs (95% CI: 0.076 to
0.004) for Trials 1-3 and 0.057 SDs (0.096 to 0.017)
for List B. As compared with the effect of age at MRI-1
(bage = 0.010; P = 0.017) in the same model on post
MRI-1 change in CVLT Trials 1–3, the magnitude of the
adverse exposure effect (per interquartile increment of
PM2.5) was equivalent to 4 years of accelerated decline
in immediate recall/new learning performance. Overall, the
multicovariate-adjusted average rate of change was signifi-
cantly accelerated by 19.3% (95% CI: 1.9% to 36.2%) for
Trials 1–3 and 14.8% (4.4% to 24.9%) for List B.
Mediation analyses involving AD-PS
scores
The results of the multilevel SEMs with parallel process
mediation are presented in Table 3. PM2.5 exposure was
associated with an increased AD-PS score (bPM2.5 on AD-PS
= 0.018; 95% CI: 0.001 to 0.034). Increases in the AD-PS
score were also associated with greater declines on both
Trials 1-3 (bAD-PS on Trials 1-3 post-MRI change = 0.459;
95% CI: 0.804 to 0.115) and List B (bAD-PS on List B
post-MRI change = 0.347; 95% CI: 0.609 to 0.085) per-
formance after MRI-1. The multicovariate-adjusted indirect
Table 1 Comparison of estimated PM2.5 exposure measured at MRI-1 visit by baseline population characteristics
(n = 998)
Population characteristics n (%) Distribution of 3-year average PM2.5a Pb
Mean SD 25th Median 75th
Overall 998 11.63 2.41 10.1 10.8 13.0
Region of residence 50.01
Northeast 174 (17.4) 11.62 1.36 10.7 11.2 12.6
South 156 (15.6) 10.98 1.42 9.8 10.2 12.3
Midwest 398 (39.9) 11.53 2.10 10.2 10.5 14.0
West 270 (27.1) 12.16 3.47 10.1 10.8 14.5
Race/ethnicity 50.01
African-American 42 (4.2) 13.44 2.59 12.0 13.0 14.3
Hispanic white 13 (1.3) 12.34 2.38 10.6 11.5 13.7
Non-Hispanic white 918 (92) 11.52 2.33 10.1 10.7 12.6
Other or missing 25 (2.5) 12.13 3.44 10.2 11.3 12.7
Education 0.05
Less than high school 36 (3.6) 11.62 2.25 10.4 11.2 13.5
High school 210 (21) 11.27 1.96 10.1 10.6 11.6
More than high school 752 (75.4) 11.73 2.52 10.1 10.8 13.2
Employment 0.28
Currently working 185 (18.5) 11.40 2.53 10.1 10.6 12.3
Not working 99 (9.9) 11.84 2.33 10.2 10.9 13.4
Retired 714 (71.5) 11.66 2.38 10.1 10.8 13.0
Income, in USD 0.03
59999 198 (19.8) 11.29 2.05 10.2 10.7 11.8
10 000–34 999 299 (30) 11.59 2.38 10.0 10.7 13.0
35 000–49 999 230 (23) 11.62 2.40 10.1 10.7 12.8
50 000–74 999 141 (14.1) 11.77 2.64 10.2 10.9 13.2
75 000 or more 100 (10) 12.28 2.71 10.4 11.0 14.5
Don’t know 30 (3) 11.59 2.41 10.1 11.1 13.2
Lifestyle
Smoking status 0.26
Never smoked 584 (58.5) 11.67 2.42 10.2 10.8 13.0
Past smoker 376 (37.7) 11.52 2.34 10.1 10.7 12.6
Current smoker 38 (3.8) 12.14 2.72 10.1 11.1 14.1
Alcohol use 0.30
Non-drinker 131 (13.1) 11.85 2.46 10.1 11.0 13.5
Past drinker 157 (15.7) 11.56 2.23 10.1 10.7 13.0
Less than one drink per day 596 (59.7) 11.54 2.37 10.1 10.7 12.5
More than one drink per day 114 (11.4) 11.92 2.73 10.3 11.0 13.2
Moderate or strenuous activities 520 min 0.15
No activity 547 (54.8) 11.66 2.44 10.1 10.8 13.2
Some activity 57 (5.7) 12.01 2.35 10.4 10.8 14.3
2–4 episodes/week 214 (21.4) 11.73 2.48 10.2 10.7 13.0
54 episodes/week 180 (18) 11.30 2.18 10.0 10.8 12.2
Physical health
Hypertension 0.78
No 644 (64.5) 11.61 2.44 10.1 10.8 13.0
Yes 354 (35.5) 11.66 2.35 10.2 10.7 12.9
High cholesterol 0.10
No 827 (82.9) 11.57 2.37 10.1 10.7 12.9
Yes 171 (17.1) 11.91 2.58 10.3 10.9 13.3
Diabetes mellitus 0.62
No 969 (97.1) 11.64 2.43 10.1 10.7 13.0
Yes 29 (2.9) 11.41 1.33 10.6 10.9 12.3
Cardiovascular disease 0.39
No 857 (85.9) 11.60 2.41 10.1 10.8 12.8
Yes 141 (14.1) 11.79 2.40 10.2 10.7 13.7
Hormone treatment ever 0.77
No 520 (52.1) 11.61 2.28 10.2 10.7 12.9
Yes 478 (47.9) 11.65 2.53 10.1 10.8 13.0
aPM2.5 represents the 3-year exposures aggregated from the daily exposure levels estimated at each residential location prior MRI-1 visit time using the Bayesian maximum entropy
spatiotemporal model.
bP-values estimated from ANOVA tests comparing average exposure.
PM2.5 effects on post MRI-1 changes were statistically sig-
nificant for both Trials 1-3 (IndirectPM2.5 on Trials 1-3 post-MRI
change = 0.008; 95% CI: 0.0262 to 0.0002) and List B
performance (IndirectPM2.5 on List B post-MRI change = 0.006;
95% CI: 0.0170 to 0.0002). Together, the estimated
change in AD-PS significantly mediated the observed asso-
ciation between PM2.5 exposure and post MRI-1 declines
of both Trials 1–3 and List B performance. In fully-adjusted
models, the mediation path that linked PM2.5 exposure
with accelerated declines of episodic memory by increasing
the AD-PS score explained 22.6% (95% CI: 1.0% to
68.9%) and 10.7% (1.0% to 30.3%) of the adverse effects
on CVLT performance in Trials 1–3 and List B perform-
ance, respectively.
Sensitivity analyses
In the analysis further adjusting for census track-level
socioeconomic characteristics of residential neighbourhood,
the findings were robust (Supplementary Tables 3 and 4).
After excluding 31 older females with incident dementia,
the association with CVLT decline in Trials 1-3 was mod-
estly attenuated and became marginally significant (P =
0.056), but the corresponding association with CVLT de-
cline in List B performance remained statistically significant
(Supplementary Table 5). Importantly, excluding the inci-
dent dementia cases only caused minimal changes to the
results on mediation by increased AD-PS scores
(Supplementary Table 6). Furthermore, the overall patterns
of observed associations, including the estimates of adverse
PM2.5 effect and results of mediation analyses, were robust
after excluding 17 females with incident clinical stroke by
2010 and further adjusting for global SVID (Supplementary
Tables 7 and 8). When the change in total grey matter
volume was assumed as a mediator of PM2.5 effect on
changes in CVLT performance, we found the direct
PM2.5 effects on decline of immediate recalls/new learning
remained statistically significant, but global change in grey
matter did not play any significant role in mediating the
observed associations (Supplementary Table 9). Lastly,
allowing CVLT change before MRI-1 to covary with
PM2.5 exposure (Supplementary Tables 10 and 11) or re-
gressing change after MRI-1 only on selected covariates
(age at MRI-1; geographic region of residence; household
income) predictive of the post MRI-1 trajectories
(Supplementary Tables 12 and 13) did not have any not-
able impacts on the results.
Discussion
In this prospective study on older females, our findings
suggest that long-term exposure to ambient PM2.5 at resi-
dential locations was associated with accelerated declines in
episodic memory, specifically in the measures of immediate
recall and new learning. Using a parallel-process SEM ap-
proach, we further demonstrated that the PM2.5-associated
greater decline in episodic memory (immediate recall and
new learning) was partly (10–22%) mediated by increasing
AD-PS scores (a structural brain MRI-based neuroanatomic
biomarker reflecting high-dimensional grey matter atro-
phies in brain areas vulnerable to Alzheimer’s disease
neuropathology). These observed associations could not
be explained by socio-demographic factors (age, geographic
Table 2 Associations between 3-year average PM2.5 (per IQR of 2.81 kg/m
3) exposure and estimated trajectories of
CVLT performance
CVLT measures Unadjusted Fully-adjusted
b (95% CI) b (95% CI)
Estimatesa of PM2.5 effects on CVLT performance at MRI-1
b
Trials 1–3 0.014 (0.043, 0.070) 0.002 (0.052, 0.057)
List B 0.045 (0.002, 0.091) 0.041 (0.003, 0.084)
Short-delay free recall 0.011 (0.067, 0.028) 0.017 (0.071, 0.038)
Long-delay free recall 0.017 (0.073, 0.038) 0.026 (0.080, 0.029)
Composite score 0.008 (0.063, 0.046) 0.017 (0.070, 0.036)
Estimatesa of PM2.5 effects on the annual change in CVLT performance after MRI-1
c)
Trials 1–3 0.039 (0.075, 0.004) 0.040 (0.076, 0.004)
List B 0.053 (0.093, 0.014) 0.057 (0.096, 0.017)
Short-delay free recall 0.009 (0.046, 0.028) 0.007 (0.045, 0.031)
Long-delay free recall 0.006 (0.045, 0.033) 0.002 (0.041, 0.037)
Composite score 0.020 (0.052, 0.013) 0.018 (0.051, 0.015)
aAll estimates derived from the multilevel structural equation model (SEM) as depicted in Fig. 2A.
bEstimates correspond to the bPM2.5 on CVLT level parameter depicted in Fig. 2A. In fully adjusted models, the effect of PM2.5 on CVLT performance at MRI-1 was adjusted for age at
MRI-1, race/ethnicity, geographic region of residence, education, household income, employment status, lifestyle factors (smoking, alcohol use, physical activities) and clinical
characteristics (use of hormone treatment; hypercholesterolaemia, hypertension, diabetes, and history of cardiovascular disease).
cEstimates correspond to the bPM2.5 on post-MRI change parameter depicted in Fig. 2A. In fully-adjusted models, the effect of PM2.5 on change in CVLT performance after MRI-1 was
adjusted for age at MRI-1, race/ethnicity, geographic region of residence, education, household income, employment status, lifestyle factors (smoking, alcohol use, physical activities)
and clinical characteristics (use of hormone treatment; hypercholesterolaemia, hypertension, diabetes, and history of cardiovascular disease).
Bolded estimates denote PM2.5 effects that are statistically significant at P 5 0.05.
region, race/ethnicity, education, income), lifestyle
(smoking, alcohol, physical activity), employment status,
clinical characteristics (diabetes, high cholesterol,
hypertension, cardiovascular diseases, hormone therapy),
or MRI-measured cerebrovascular disease, and remained
measurable after excluding incident cases of dementia and
stroke. In contrast, we found no evidence of statistically
significant associations between PM2.5 exposure and the
observed declines in delayed-recall or the composite meas-
ure of episodic memory. To our knowledge, this is the first
study to suggest that long-term PM2.5 exposure accelerates
the early cognitive decline commonly seen before the de-
mentia onset, and this putative neurotoxic effect in the pre-
clinical stage is mediated by altered brain structure that
predicts subsequent Alzheimer’s disease risk.
Previous studies on air pollution and cognitive decline
had yielded inconsistent results (Peters et al., 2019), but
our data provide the most compelling epidemiological evi-
dence so far to support the adverse effect on the preclinical
trajectories of episodic memory in older females affected by
PM2.5 exposure in late life, suggesting the long-term air
pollution neurotoxicity across the Alzheimer’s disease con-
tinuum. Episodic memory is one of the cognitive domains
with early declines detectable in preclinical Alzheimer’s dis-
ease (Aisen et al., 2017). Three cohort studies had exam-
ined the association between PM2.5 exposure and episodic
memory decline, but their reported findings were mixed,
including no significant association in the Nurses’ Health
Study (Weuve et al., 2012), a positive association in the
Boston Puerto Rican Health Study (Wurth et al., 2018)
and a negative association (with a single measure of imme-
diate recall) in the Whitehall II study (Tonne et al., 2014).
These three reports were limited by only two to three cog-
nitive assessments, and so far none of these cohort studies
had examined the association between exposure and inci-
dent dementia or clinically significant cognitive impairment.
Investigators in the Betula Project in Sweden possibly made
the first attempt to establish the air pollution exposure
effect continuum in dementia. They found nitrogen oxide
exposure was associated with increased dementia risk
(Oudin et al., 2016), but not with episodic memory decline
(Oudin et al., 2017). The exact reasons for this discrepancy
were unclear, because episodic memory measured 10 years
prior to clinical diagnosis significantly predicted dementia
in the Betula cohort (Boraxbekk et al., 2015). One possible
explanation is that the air pollution neurotoxicity observed
in the Swedish cohort only accelerated the pathological
brain ageing process during the clinical stage. However,
this interesting hypothesis was not supported by the neuro-
toxicological data showing that diesel engine exhaust accel-
erated amyloid-b plaque formation, with no overt deficits
in spatial memory (Hullmann et al., 2017). In contrast, we
have previously reported that residing in locations with
high PM2.5 exposure was associated with clinically signifi-
cant cognitive impairment and dementia among non-
Hispanic white older females from WHIMS (Cacciottolo
Table 3 Multilevel SEMs with parallel process mediation to examine whether increased Alzheimer’s disease pattern
similarity scores mediate the adverse PM2.5 effects (per IQR of 2.81 mg/m
3) on declines of immediate recall/new
learning
CVLT Trials 1–3 CVLT List B
Unadjusted Adjusted Unadjusted Adjusted
b (95% CI) b (95% CI) b (95% CI) b (95% CI)
Estimatesa of direct effect
Effect of PM2.5 on annual
change in CVLT per-
formance after MRI-1,
accounting for the in-
direct effectb
0.024 (0.059, 0.012) 0.030 (0.089, 0.008) 0.045 (0.085, 0.006) 0.049 (0.089, 0.010)
Estimatesa of indirect effect
Effects of PM2.5 on the
increase of in AD-PS
scoresc
0.022 (0.006, 0.039) 0.018 (0.001, 0.034) 0.022 (0.006, 0.039) 0.018 (0.001, 0.034)
Effects of increased AD-
PS score on annual
change in CVLT per-
formance after MRI-1d
0.592 (0.913, 0.271) 0.459 (0.804, 0.115) 0.333 (0.587, 0.079) 0.347 (0.609, 0.085)
Proportion of total PM2.5
effect mediated by
increased AD-PS scores
35.1% (6.2%, 78.1%) 22.6% (1%, 68.9%) 13.2% (1.3%, 35.1%) 10.7% (1%, 30.3%)
Estimates bolded if statistically significant at P 5 0.05. AD-PS was z-score standardized based on the mean and SD at WHIMS MRI-1.
aAll estimates derived from the multilevel structural equation models with parallel process mediation as depicted in Fig. 2B. In fully-adjusted models, all the presented effect estimates
on CVLT decline (direct PM2.5 effects; indirect effect paths, including CVLT decline affected by increased AD-PS scores) were adjusted for age at MRI-1, race/ethnicity, attrition,
geographic region of residence, education, household income, employment status, lifestyle factors (smoking, alcohol use, physical activities), and clinical characteristics (use of
hormone treatment; hypercholesterolaemia, hypertension, diabetes, and history of cardiovascular disease).
bEstimate corresponds to the bPM2.5 on post-MRI change parameter depicted in Fig. 2B.
cEstimate corresponds to the bPM2.5 on AD-PS parameter depicted in Fig. 2B.
et al., 2017). In the current study using data from WHIMS
participants who were tested with CVLT annually for the
WHISCA, we further found that PM2.5 exposure was asso-
ciated with greater declines in episodic memory (immediate
recall and new learning), equivalent to 4 years of accel-
erated decline. These findings were observed even among
cognitively intact older females without dementia. We also
showed these observed adverse PM2.5 effects on accelerated
decline in episodic memory were partly mediated by the
increased AD-PS score, an earlier biomarker reflecting the
neuroanatomic risk associated with progressive grey matter
atrophy in brain regions vulnerable to Alzheimer’s disease
neuropathology. Although our collective findings point to
the possible continuum of PM2.5 neurotoxicity across the
early neuropsychological processes and altered brain struc-
tures predictive of subsequent dementia risk, we call for
future studies to replicate our results in other populations
and to further substantiate the scientific evidence of the
continuum of air pollution neurotoxicity in the preclinical
stage.
Our study illustrates the promise of new approaches to
understanding the neuropsychological processes and altered
brain structure associated with air pollution exposure.
First, to the best of our knowledge, this was the first air
pollution epidemiological study to combine both longitu-
dinal brain MRI and cognitive function data, allowing us
to investigate the brain–behaviour relations affected by
PM2.5 neurotoxicity. Such combined neuroimaging-neuro-
psychological data analyses are important as they better
inform our understanding of the brain determinants of
the cognitive changes of Alzheimer’s disease to address im-
portant clinical and scientific challenges presented by
Alzheimer’s disease (Mungas et al., 2012). Second, using
a sophisticated parallel-process SEM, our study represents
the first application to air pollution epidemiology of brain
ageing to simultaneously model level and change in both
cognitive decline and longitudinal change in structural
brain MRI measures and further examine the hypothesized
mediation effects. This analytical approach is important be-
cause it allows researchers to directly examine complex
questions about intra-individual changes in cognitive per-
formance and neuroimaging data in a single statistical
model. Lastly, we used the AD-PS scores as a more specific
measure of altered brain structure in brain areas that are
likely more vulnerable to the Alzheimer’s disease neurode-
generative processes. In contrast, previous human studies
using neuroimaging data to investigate PM2.5 effects on
altered brain structure used the region-of-interest approach
(Chen et al., 2015; Wilker et al., 2015; Power et al., 2018)
or conducted whole-brain analyses (Casanova et al., 2016),
and none of these studies found a significant association
with the volumes of hippocampus, which is not specific
to Alzheimer’s disease (Frisoni et al., 2010). Also, the ma-
jority of these previous studies (Chen et al., 2015; Wilker
et al., 2015; Casanova et al., 2016) did not evaluate the
possibility that PM2.5 neurotoxicity may result in brain
atrophy with unique spatial patterns, similar to the
spreading of neurodegenerative proteins as shown in
many neuropathological studies in Alzheimer’s disease
(Brettschneider et al., 2015). Although Power et al.
(2018) also studied grey matter volumes in brain regions
vulnerable to Alzheimer’s disease neuropathology, a few
methodological differences were noteworthy. For instance,
Power et al. investigated the putative neurotoxic effects of
PM2.5 on brain volumes measured at one time point, while
we conducted a longitudinal study based on changes of
AD-PS score across two time points (2005–06 and 2009–
10). Additionally, the ‘Alzheimer’s disease signature re-
gions’ used by Power et al. were selected based on work
by Dickerson et al. (2011) applying a hypothesis-driven
region-of-interest approach. In contrast, to create the AD-
PS score, we took a data-driven approach using supervised
machine learning based on a large-scale regularization al-
gorithm that analyses whole-brain grey matter tissue at the
voxel-level and identifies the unique spatial patterns of
localized grey matter atrophy in Alzheimer’s disease.
Our empirical data pointed to the possibility that PM2.5
neurotoxicity may have differential effects across the epi-
sodic memory processes, although the biological underpin-
nings of such observed differences are unclear. Published
work on PM2.5 and episodic memory decline had found
an unexpected positive association in the Boston Puerto
Rican Health Study (Wurth et al., 2018) and no statistically
significant association in the Nurses’ Health Study (Weuve
et al., 2012), both using a composite measure, which ig-
nores the important heterogeneity in the neuropsycho-
logical processes that comprise episodic memory
performance. In the present study, we were able to show
the differential effects of PM2.5 exposure on episodic
memory, with the exposure-associated decline predomin-
antly affecting immediate recall and new learning and no
significant association with delayed-recall ability or our
composite measure of episodic memory. In the Baltimore
Longitudinal Study of Aging, declines in CVLT immediate
recall/encoding processes were observed first with
Alzheimer’s disease progression, followed by changes in
long-delayed free recall scores, suggesting that changes in
immediate recall/new learning may take place earlier during
the preclinical stages of Alzheimer’s disease (Bilgel et al.,
2014). Thus, the observation of differential exposure effects
on CVLT measures reinforces the suggestion that our study
was capturing the PM2.5 neurotoxic effects on the early
neuropsychological processes of episodic memory decline
at the preclinical stage. The medial temporal lobe and the
interactions of its structural components play a central role
in the episodic memory (Dickerson and Eichenbaum,
2010). Early studies have documented the functional speci-
fication of the prefrontal cortex involved in different cog-
nitive processes in episodic memory (Fletcher et al., 1998a,
b). More recent studies further demonstrated the distinctive
roles of large-scale cortical networks contributing to the
different cognitive processes of episodic memory in individ-
uals with prodromal (Putcha et al., 2019) and clinical
Alzheimer’s disease (Wolk et al., 2011). Future studies
need to continue examining the possibly differential expos-
ure effects on the episodic memory processes and further
elucidate how these related neural networks are affected by
PM2.5 neurotoxicity.
Our study results, as well as the growing literature on air
pollution neurotoxicity, point to several important direc-
tions for advancing the environmental neurosciences of
brain ageing associated with exposure to ambient particles.
We found that long-term PM2.5 exposure was associated
with increasing AD-PS scores, which only accounted for
10–22% the PM2.5-associated greater decline in episodic
memory, and the direct exposure effects remained statistic-
ally significant (Table 3). Other contributors to the
observed episodic memory decline associated with PM2.5
exposure may include the alteration of other brain struc-
tures, changes in neural networks, and specific neuropatho-
logical processes, not fully captured by the increased AD-PS
scores. For example, hippocampal subfields may be critical
targets of the air pollution neurotoxicity on the neuropsy-
chological processes of episodic memory decline. The
medial temporal lobe and its structural components (espe-
cially the hippocampus) play a central role in encoding
(learning; recall) and retrieving (recall) details of events
that compose episodic memories (Dickerson and
Eichenbaum, 2010). Although the roles of hippocampal
subfields [e.g. cornu ammonis (CA, CA2-3), CA4-denate
gyrus, presubiculum, subiculum] on these distinct processes
(encoding, retrieval) remain to be delineated, animal studies
have demonstrated the adverse effects of particulate matter
and its constituents on morphological and functional
changes within hippocampal subfields. For instance,
decreased apical dendritic spine density and dendritic
branches in the CA1 and CA3 regions (Fonken et al.,
2011), reduced synaptic function (Ku et al., 2017) in
CA1 neurons (Davis et al., 2013), and decreased myelin
basic protein in white matter and increased atrophy of
neurites in the CA1 region (Woodward et al., 2017) have
been observed. These neurotoxicological data collectively
suggest that some hippocampal subfields may be more sen-
sitive than others to the adverse particulate matter effects.
Additionally, human imaging studies (Zhao et al., 2019)
have found that atrophy in hippocampal subfields imposed
varying degrees of influences on different measures of epi-
sodic memory (immediate recalls; delayed-recalls; recogni-
tion). Previous research also suggests that the CA2, CA3,
and dentate gyrus are responsible for encoding, while the
CA1 and subiculum are responsible for retrieval (Zammit
et al., 2017). Our findings of significant declines predom-
inantly in immediate recall/new learning imply that the ad-
verse PM2.5 effects on episodic memory processes may be
more targeted towards hippocampal subfields related to
encoding, such as the CA2, CA3, and dentate gyrus.
High-resolution neuroimaging studies are needed to deter-
mine whether there is indeed a subfield neurotoxicity
involved. Next, studies have shown that cerebrovascular
disease, MRI measures of vascular brain injury (e.g. white
matter hyperintensities; infarcts), and vascular risk factors
are independently associated with cognitive decline
(Marchant et al., 2013; DeCarli et al., 2019). Our explora-
tory analyses showed robust findings even after further
adjustment for global SVID volume (a proxy for cerebro-
vascular damage) or excluding females with incident
clinical stroke. Although these results suggest that the
observed mediation by increased AD-PS score associated
with late-life exposure to PM2.5 may be independent of
large-vessel diseases or global cerebrovascular damage, it
is important not to rule out other measures of cerebral
small-vessel diseases (e.g. microbleeds, cerebral amyloid
angiopathy) for their potential contributions to the
exposure effects on episodic memory declines. Lastly,
other neuropathological processes underlying the observed
mediation by increasing AD-PS scores are unclear. Meta-
analyses of studies with PET scans of cognitively-normal
individuals found that high amyloid-b status predicts
subsequent decline in episodic memory (Baker et al.,
2017). PET studies have also shown that grey matter
atrophy may be a consequence of tau neuropathological
processes, which in turn may be driving the observed cog-
nitive decline (Bejanin et al., 2017; Jagust, 2018; Harrison
et al., 2019). Future neuroimaging studies are needed to
determine whether specific neuropathological processes
(e.g. aggregation of phosphorylated tau in neurofibrillary
tangles; amyloid-b plaque deposition) drive the PM2.5-asso-
ciated greater decline in episodic memory.
We recognize several limitations of our study. First, al-
though the BME spatiotemporal models were well cross-
validated (average Pearson’s R2 = 0.70) to estimate PM2.5
exposures, these resulting estimates were still subject to
measurement errors because individual-level data on
time-activity patterns of our study participants were not
available. However, such estimation errors tend to be
non-differential, most likely resulting in attenuation of the
observed associations. Second, we were unable to estimate
early- or mid-life PM2.5 exposures, because nationwide
PM2.5 monitoring data were unavailable prior to 1999
and early-life residential location data were not collected
in WHI. Since air pollution levels have been declining
over the past two decades, early- or mid-life PM2.5 expos-
ure effects could have been greater than or different from
what we observed in our study on late-life exposure. Third,
our study focused on regional PM2.5 only, and we did not
investigate its chemical constituencies (e.g. black carbon;
inorganic secondary aerosols), other exposure sources
(e.g. from near roadways), or possible interactions with
other pollutant mixtures (e.g. with photochemical reactions
of gaseous pollutants). Fourth, although our sensitivity ana-
lyses suggest stroke and cerebrovascular disease damage
could not explain the observed adverse PM2.5 effects on
episodic memory decline, we did not examine multiple me-
diation pathways involving longitudinal SVID changes.
Extant literature on air pollution neuroimaging studies do
not support the association between late-life exposure to air
pollution and MRI-measured cerebrovascular damage
(Chen et al., 2015; Wilker et al., 2015, 2016; Kulick
et al., 2017; Power et al., 2018), but it remains possible
that PM2.5 exposures before late-life could impart adverse
effects that we may have missed in the current study. Fifth,
we could not completely rule out the possibility of
unmeasured confounding by other environmental factors
(e.g. outdoor noise; neighbourhood green space) that may
be correlated with PM2.5. However, the extant epidemiolo-
gic data do not provide strong evidence for these environ-
mental factors to accelerate episodic memory decline at the
preclinical stage; therefore, their role as potential confoun-
ders is not well-established. Lastly, our findings may not be
generalizable to males or younger females.
This study also had several major strengths. First, females
were prospectively followed over a long period of time
(11 years), with annual assessments of both their imme-
diate- and delayed-recall, allowing us to examine whether
of PM2.5-exposure was differentially associated with these
cognitive processes. Second, we used the sophisticated par-
allel-process mediation SEM approach, which allowed us to
examine whether PM2.5 effects level and change of episodic
memory performance, while also investigating to what
extent AD-PS scores may mediate this association. Third,
our AD-PS scores were able to capture the spatial patterns
of brain tissue atrophy more specific to Alzheimer’s disease.
Lastly, the rich, comprehensive data of the geographically
diverse WHIMS cohort allowed us to adjust for potential
confounding by multiple covariates and address other
sources of biases.
In summary, this study provided the first epidemiolo-
gical evidence suggesting long-term PM2.5 exposure in
late life is associated with accelerated decline of episodic
memory, predominantly affecting immediate recall and
new learning. Increases in neuroanatomical risk for
Alzheimer’s disease associated with PM2.5 partially ex-
plained these negative associations. The adverse effects
remained measurable even after excluding incident
dementia, suggesting the possible continuum of PM2.5
neurotoxicity that may contribute to early decline of im-
mediate recall and new learning abilities at the preclinical
stage. Because this is the first study of its kind combining
both longitudinal data on cognitive decline and a neuroa-
natomic risk score for Alzheimer’s disease, replication of
our findings will be needed to substantiate the suggestion
for continuum of air pollution neurotoxicity. Future neu-
roimaging studies are needed to further explore the links
between episodic memory processes and altered brain
structures, especially hippocampal subfields and other
related neural networks, underpinning the observed asso-
ciation between PM2.5 and dementia risk.
Acknowledgement
The investigators appreciate Dr Eric Whitsel for assisting in
post-estimation data processing and delivering of pollution
exposure data and neighborhood contextual data used in
this study.
Funding
The results reported herein correspond to the specific aims
of R01ES025888 from the National Institute of
Environmental Health Sciences. The air pollution exposure
data were derived from the R01AG033078 (PI: J-C.C.) and
the AD-PS score data were generated from R21AG051113
(PI: R.C. and J-C.C.), both supported by the National
Institute on Aging. This work is also supported by
R01AG033078 (PI: J-C.C.) and RF1AG054068 (PI: J-
C.C.). D.Y., A.J.P., X.W., M.A.E. and J-C.C. are also sup-
ported by RF1AG054068 (PI: J-C.C.). D.Y. and J-C.C are
also supported by P01AG055367. Research work of D.Y.
and J-C.C. are also supported by the Southern California
Environmental Health Sciences Center (5P30ES007048).
H.C.C. is supported by P50AG05142. R.C., M.A.E., and
S.R.R. receive funding from the Wake Forest Alzheimer’s
Disease Core Center (P30AG049638–01A1). S.M.R. is sup-
ported by the Intramural Research Program, National
Institute on Aging, NIH. V.W.H. is supported by
P50AG047366. The WHI programs is funded by the
National Heart, Lung, and Blood Institute, National
Institutes of Health, US Department of Health and
Human Services through contracts, HHSN268201100
046C, HHSN268201100001C, HHSN268201100002C,
HHSN268201100003C, HHSN268201100004C and HH
SN271201100004C. For a list of all the investigators
who have contributed to WHI science, please visit:
https://www.whi.org/researchers/Documents%20%20Write
%20a%20Paper/WHI%20Investigator%20Long%20List.pdf.
The Women’s Health Initiative Memory Study was
funded cas an ancillary study to the WHI by Wyeth
Pharmaceuticals, Inc., Wake Forest University; and the
National Heart, Lung, and Blood Institute, National
Institutes of Health; and the National Institute of Aging,
National Institutes of Health (contract number HHSN271-
2011-00004C). The Women’s Health Initiative Magnetic
Resonance Imaging Study was funded by contract N01-
WH-44221, from the National Heart, Lung, and Blood
Institute.
Competing interests
The authors report no competing interests.
Supplementary material
Supplementary material is available at Brain online.
References
Aisen PS, Cummings J, Jack CR, Morris JC, Sperling R, Frölich L,
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